Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma
Titel:
Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma
Auteur:
Eggermont, Alexander M.M. Blank, Christian U. Mandala, Mario Long, Georgina V. Atkinson, Victoria G. Dalle, Stéphane Haydon, Andrew Lichinitser, Mikhail Khattak, Adnan Carlino, Matteo S. Sandhu, Shahneen Larkin, James Puig, Susana Ascierto, Paolo A. Rutkowski, Piotr Schadendorf, Dirk Koornstra, Rutger Hernandez-Aya, Leonel Di Giacomo, Anna Maria van den Eertwegh, Alfonsus JM. Grob, Jean-Jacques Gutzmer, Ralf Jamal, Rahima Lorigan, Paul C. Lupinacci, Robert Krepler, Clemens Ibrahim, Nageatte Kicinski, Michal Marreaud, Sandrine van Akkooi, Alexander C. Suciu, Stefan Robert, Caroline